Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
The only current strategy to test efficacy of novel interventions for sustained HIV control without antiretroviral therapy (ART) among people with HIV (PWH) is through an analytical treatment interruption (ATI). Inclusion of ‘placebo’ controls in ATIs poses ethical, logistical, and economic challeng...
Auteurs principaux: | Gunst, JD, Gohil, J, Li, JZ, Bosch, RJ, White, Catherine Seamon, A, Chun, T, Mothe, B, Gittens, K, Praiss, L, De Scheerder, M, Vandekerckhove, L, Escandón, K, Thorkelson, A, Schacker, T, SenGupta, D, Brander, C, Papasavvas, E, Montaner, LJ, Martinez-Picado, J, Calin, R, Castagna, A, Muccini, C, de Jong, W, Leal, L, Tipoe, T, Frater, J |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Nature Research
2025
|
Documents similaires
-
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
par: Jesper D. Gunst, et autres
Publié: (2025-01-01) -
To rebound or not to rebound
par: Bethany A Stahl, et autres
Publié: (2017-10-01) -
Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption
par: Leila B. Giron, et autres
Publié: (2021-02-01) -
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
par: Hurst, J, et autres
Publié: (2015) -
Operational complexity and supplier-customer integration: case study insights and complexity rebound.
par: Sivadasan, S, et autres
Publié: (2010)